United States securities and exchange commission logo





                             June 30, 2022

       James Mock
       Chief Financial Officer
       PerkinElmer, Inc.
       940 Winter Street
       Waltham, MA 02451

                                                        Re: PerkinElmer, Inc.
                                                            Form 10-K for the
Fiscal Year Ended January 2, 2022
                                                            Filed March 3, 2022
                                                            Form 10-Q for the
Quarterly Period Ended April 3, 2022
                                                            Filed May 10, 2022
                                                            File No. 001-05075

       Dear Mr. Mock:

              We have limited our review of your filing to the financial
statements and related
       disclosures and have the following comment. In some of our comments, we
may ask you to
       provide us with information so we may better understand your disclosure.

              Please respond to this comment within ten business days by
providing the requested
       information or advise us as soon as possible when you will respond. If
you do not believe our
       comment applies to your facts and circumstances, please tell us why in
your response.

                                                        After reviewing your
response to this comment, we may have additional comments.

       Form 10-Q for the Quarterly Period Ended April 3, 2022

       Item 2. Management's Discussion and Analysis of Financial Condition and
Results of
       Operations, page 25

   1.                                                   Please discuss in
future filings whether supply chain disruptions or inflation
                                                        have materially
affected your outlook or business goals. Specify whether these challenges
                                                        have materially
impacted your results of operations or capital resources and quantify, to
                                                        the extent possible,
how your sales, profits, and/or liquidity have been impacted. Revise
                                                        also to discuss in
future filings any known trends or uncertainties resulting from
                                                        mitigation efforts
undertaken, if any. Explain whether any mitigation efforts introduce
                                                        new material risks,
including those related to product quality, reliability, or regulatory
                                                        approval of products.
 James Mock
PerkinElmer, Inc.
June 30, 2022
Page 2

       In closing, we remind you that the company and its management are
responsible for the
accuracy and adequacy of their disclosures, notwithstanding any review,
comments, action or
absence of action by the staff.

       You may contact Lynn Dicker at (202) 551-3616 or Tara Harkins, Senior
Accountant, at
(202) 551-3639 with any questions.



FirstName LastNameJames Mock                              Sincerely,
Comapany NamePerkinElmer, Inc.
                                                          Division of
Corporation Finance
June 30, 2022 Page 2                                      Office of Life
Sciences
FirstName LastName